Abstract
Viral inclusion bodies (IBs) commonly form during the replication of Ebola virus (EBOV) in infected cells, but their role in viral immune evasion has rarely been explored. Here, we found that interferon regulatory factor 3 (IRF3), but not TANK-binding kinase 1 (TBK-1) or IκB kinase epsilon (IKKε), was recruited and sequestered in viral IBs when the cells were infected by EBOV transcription- and replication-competent virus-like particles (trVLPs). NP/VP35-induced IBs formation was critical for IRF3 recruitment and sequestration, probably through interaction with STING. Consequently, the association of TBK1 and IRF3, which plays a vital role in type I interferon (IFN-I) induction, was blocked by EBOV trVLPs infection. Additionally, IRF3 phosphorylation and nuclear translocation induced by Sendai virus (SeV) or poly(I:C) stimulation were suppressed by EBOV trVLPs. Furthermore, downregulation of STING significantly attenuated VP35-induced IRF3 accumulation in IBs. Coexpression of the viral proteins by which IBs-like structures formed was much more potent in antagonizing IFN-I than expression of the IFN-I antagonist VP35 alone. These results suggested a novel immune evasion mechanism by which EBOV evades host innate immunity.
Introduction
The innate immune system serves as the body's primary defense, utilizing Type I Interferons (IFN-I) to restrict viral spread. A central component of this pathway is the transcription factor IRF3. Upon activation, IRF3 translocates to the nucleus to initiate the expression of antiviral genes. Ebola virus (EBOV) is remarkably efficient at neutralizing this response. While the viral protein VP35 was previously identified as an interferon antagonist, the mechanism behind EBOV's comprehensive immune blockade remained partially understood. This study investigates whether EBOV-induced Inclusion Bodies (IBs)—cytoplasmic sites of viral replication—function as physical traps to sequester host immune proteins.
Methods and Experimental Approach
To investigate these mechanisms safely, researchers utilized trVLPs (Transcription- and Replication-Competent Virus-Like Particles), which replicate the EBOV life cycle without the pathogenicity of the live virus. Key methodologies included:
- Advanced Imaging: Confocal microscopy and Transmission Electron Microscopy (TEM) visualized the spatial organization of IBs and the localization of host proteins.
- Molecular Interaction Assays: Proximity Ligation Assay (PLA) and Co-Immunoprecipitation (Co-IP) determined physical interactions between viral and host proteins.
- Functional Assays: Luciferase reporter assays measured the interferon response, while siRNA-mediated knockdown of STING assessed its role in IRF3 sequestration.
Key Insights: The "Viral Jail" Mechanism
Selective Sequestration
The study reveals that IBs are not merely replication factories but act as "jails" for specific host proteins. By 48 hours post-infection, cellular IRF3 is predominantly sequestered within these viral structures. Crucially, this sequestration is selective: while IRF3 is trapped, the kinases responsible for its activation—TBK1 and IKKε—remain dispersed in the cytoplasm. By physically separating the activator (kinases) from the effector (IRF3), the virus prevents the initiation of the immune alarm.
STING as a Hijacked Mediator
A significant finding is the role of STING, a host protein typically involved in DNA virus detection. EBOV hijacks STING to facilitate the recruitment of IRF3 into IBs. VP35 interacts with STING, which then acts as a molecular bridge to pull IRF3 into the viral structures. Knocking down STING significantly reduces the virus's ability to trap IRF3, highlighting a novel exploitation of host defense machinery.
Key Results and Functional Impact
- Spatial Isolation: Imaging confirmed a high degree of co-localization between viral NP/VP35 and host IRF3 within IBs, while TBK1 remained isolated.
- Functional Blockade: Infection with trVLPs significantly reduced the physical association between TBK1 and IRF3, a necessary step for IRF3 activation.
- Potent Antagonism: The physical structure of the IB itself appears critical for virulence. Co-expression of the proteins required for IB formation (NP, VP35, L, and VP30) suppressed IFN-β transcription far more effectively than the expression of VP35 alone.
Limitations and Future Directions
While the study provides strong evidence for IRF3 sequestration, some aspects require further clarification. Reviewers noted that the "strength of evidence" regarding the absolute necessity of the IB structure versus the individual proteins remains to be fully solidified with additional control groups. Furthermore, the precise biochemical interaction between VP35, STING, and IRF3 at the atomic level is yet to be mapped.
Understanding this "kidnapping" mechanism offers a new target for therapeutic intervention. Disrupting the formation of IBs or the specific interaction between VP35 and STING could potentially release IRF3, restoring the host's ability to mount an effective antiviral response against Ebola virus.
Summary updated